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Morphogenesis of influenza virus is a poorly understood process that produces two types of enveloped virion: 100-nm
spheres and similar diameter filaments that reach 20 m in length. Spherical particles assemble at plasma membrane lipid
rafts in a process independent of microfilaments. The budding site of filamentous virions is hitherto uncharacterised but their
formation involves the actin cytoskeleton. We confirm microfilament involvement in filamentous budding and show that after
disruption of cortical actin by jasplakinolide, HA, NP, and M1 redistributed around -actin clusters to form novel annular
membrane structures. HA in filamentous virions and jasplakinolide-induced annuli was detergent insoluble at 4°C. Further-
more, in both cases HA partitioned into low buoyant density detergent-insoluble glycolipid domains, indicating that filamen-
tous virions and annuli contain reorganised lipid rafts. We propose that the actin cytoskeleton is required to maintain theINTRODUCTION
Influenza virions are enveloped by a host-derived lipid
bilayer containing three viral proteins, the haemaggluti-
nin [HA] and neuraminidase [NA] glycoproteins, involved
in entry and exit, and the M2 ion channel, which plays a
role in viral uncoating (Lamb and Krug, 1996). The viral
envelope surrounds a shell of matrix protein (M1), within
which lie the internal genomic ribonucleoprotein (RNP)
particles. Each RNP consists of one of the eight negative-
sense viral RNA segments encapsidated by nucleopro-
tein (NP) and one copy of the trimeric viral polymerase
(Portela and Digard, 2002). In addition, virion cores con-
tain a low abundance NEP/NS2 polypeptide, thought to
play a role in export of the RNPs from the cell nucleus,
the site of viral transcription (O’Neill et al., 1998).
Virions are formed by budding from the apical surface
of the plasma membrane in infected epithelial cells (Ba-
chi et al., 1969; Rindler et al., 1985). Thus the virus must
assemble its structural components within an area of the
plasma membrane which can pinch off to form a particle
of around 100 nm diameter. Historically, it has been
postulated that influenza viral glycoproteins might lo-
calise other viral components to budding domains in the
1 Present address: Department of Pathobiology, School of Veterinary
Medicine, University of Pennsylvania, 3800 Spruce Street, Philadelphia,
PA 19104-6049.© 2002 Elsevier Science (USA)
All rights reserved.
212plasma membrane (Compans and Choppin, 1975). In
support of this hypothesis, there is evidence for interac-
tions between M1 and the cytoplasmic tails of the HA
and NA glycoproteins (Enami and Enami, 1996; Jin et al.,
1997; Ali et al., 2000; Zhang et al., 2000) and for M1-RNP
interactions (Zvonarjev and Ghendon, 1980; Martin and
Helenius, 1991; Zhang and Lamb, 1996; Ye et al., 1999).
Furthermore, the advent of the lipid raft model of mem-
brane structure provides a possible mechanism for the
concentration of the viral glycoproteins and thus the
internal components into localised regions for efficient
budding. The lipid raft model states that certain species
of saturated lipid (glycosphingolipids and sphingomye-
lin), along with cholesterol, preferentially associate with
one another to form ordered domains in the plasma
membrane that incorporate a specific subset of mem-
brane proteins (Brown and Rose, 1992; Simons and
Ikonen, 1997; Brown and London, 1998). Lipid rafts have
been defined primarily by biochemical means, particu-
larly their insolubility in nonionic detergents at low tem-
peratures (Brown and Rose, 1992; Fiedler et al., 1993).
Their visual definition has been more problematic, al-
though single-particle tracking and fluorescent reso-
nance energy transfer methods suggest that they are
generally small structures on the scale of 100 nm
(Kenworthy and Edidin, 1998; Varma and Mayor, 1998;
Pralle et al., 2000; Schutz et al., 2000; reviewed by Jacob-
son and Dietrich, 1999). Thus, lipid rafts might facilitatecorrect organisation of lipid rafts for incorporation into bud
Key Words: cytochalasin D; latrunculin A; atomic force m
2 To whom correspondence and reprint requests should be ad-
dressed. Fax: 44 1223 336926. E-mail: pd1@mole.bio.cam.ac.uk.
doi:10.1006/viro.2002.1595
0042-6822/02 $35.00iral filaments. © 2002 Elsevier Science (USA)
opy.
the concentration of viral components into suitably sized
budding domains in the plasma membrane. Indeed, bothding v
icrosc
HA and NA are incorporated into lipid rafts (Scheiffele et
al., 1997, 1999; Barman and Nayak, 2000), and further-
more, virus particles from the fowl plague A/FPV/34 (FPV;
H7N1) and A/WSN/33 (WSN; reassorted to H3N1) strains
have been shown to bud from rafts and contain raft-
incorporated lipids (Van Meer and Simons, 1982;
Scheiffele et al., 1999; Zhang et al., 2000). It has also
been proposed that host cell membrane proteins are
excluded from budding influenza viruses (Compans and
Choppin, 1975; Naim and Roth, 1993). Such selectivity
could be exerted at least in part through discrimination
between raft-associated and nonraft proteins. Thus virus
exploitation of the lipid raft system potentially provides
an intrinsic mechanism for the concentration of viral
proteins and the exclusion of a large proportion of cel-
lular proteins from viral budding sites (Zhang et al., 2000).
The morphology of influenza virions varies consider-
ably. Laboratory-adapted influenza virus strains gener-
ally produce pleomorphic, approximately spherical par-
ticles with a diameter of 80–120 nm (Ruigrok et al., 1985;
Jin et al., 1997). However, in addition to spherical parti-
cles, certain strains of influenza virus also produce large
numbers of virions with a filamentous morphology (Mos-
ley and Wyckoff, 1946; Chu et al., 1949; Choppin et al.,
1960) and there is evidence that filamentous forms might
be present in vivo in the human host (Chu et al., 1949).
Filamentous virions have similar diameters to spherical
particles (100 nm), but are vastly elongated; in the case
of the A/Udorn/72 (Udorn; H3N2) strain virus particles
reach lengths of up to 30 m (Roberts and Compans,
1998). Thus, although spherical virions can be consid-
ered to be comparably sized to their putative lipid raft
budding site, filamentous virions are substantially larger.
Genetic factors affect virion shape: the matrix genes, HA,
and NA are significant in determining filament formation
(Smirnov, 1991; Roberts et al., 1998). However, host cell
factors also play a role, and in particular, the sensitivity of
filamentous (but not spherical) virus budding to cytocha-
lasin D, an inhibitor of actin polymerization, suggests that
their formation depends on an intact actin cytoskeleton
(Roberts and Compans, 1998). The precise role of actin in
assembly of filamentous morphology virions is unknown,
but unlike other viruses such as measles (Bohn et al.,
1987), actin has not been found inside influenza virions
or budding particles. Although an intact actin cytoskele-
ton is not essential for the assembly of spherical virus
particles (Griffin and Compans, 1979; Roberts and Com-
pans, 1998), there is evidence suggesting that a fraction
of the RNPs and M1 protein in infected cells is associ-
ated with microfilaments (Avalos et al., 1997; Husain and
Gupta, 1997) and NP has been shown to be an F-actin
binding protein (Digard et al., 1999, 2001).
The experiments described here were carried out to
investigate further the role of the cytoskeleton in the
formation of filamentous influenza virus particles and to
examine whether filamentous virion assembly involves
lipid rafts. Three drugs which disrupt actin treadmilling in
mechanistically distinct ways inhibited filamentous virion
production. Furthermore, drug treatment led to the spe-
cific reorganisation of HA, M1, and RNP into a previously
unrecognised annular cell-surface structure formed
around a core of aggregated -actin underlying the
plasma membrane. Filamentous virions and HA annuli
were resistant to low temperature detergent extraction
and the HA of Udorn virus was incorporated into low
buoyant density detergent-insoluble glycolipid domains
(DIGs), indicating that filamentous influenza virions bud
from lipid raft domains. We therefore suggest that the
dependence of filamentous virion assembly on the mi-
crofilament network reflects a raft–actin interaction that
maintains the necessary organisation of HA-containing
lipid rafts for their incorporation into budding particles.
RESULTS
Filamentous virion assembly and HA distribution
on the cell surface are affected by disruption
of the actin cytoskeleton
Previous work has shown that cytochalasin D inhibits
the production of filamentous but not spherical virions by
the Udorn virus, suggesting a specific requirement for
the actin cytoskeleton in the assembly of filamentous
particles (Roberts and Compans, 1998). To test further
the relevance of the actin cytoskeleton to virion assem-
bly, we examined the effects of a mechanistically differ-
ent inhibitor of actin treadmilling on influenza virus infec-
tion. Cytochalasin D prevents actin polymerisation by
binding to the barbed ends of actin filaments and block-
ing the addition of soluble (G)-actin monomers (Schliwa,
1982). We therefore tested the effects of jasplakinolide, a
drug which binds to F-actin and inhibits actin depolymer-
ization (Bubb et al., 1994) on the replication of Udorn and
A/PR/8/34 (PR8; H1N1), as representative filamentous
and nonfilamentous viruses, respectively. Polarized epi-
thelial Madin–Darby canine kidney (MDCK) cells were
infected or mock-infected with each virus for 1 h at 37°C
and then incubated in the presence or absence of vary-
ing concentrations of jasplakinolide. At 8 h p.i., cell su-
pernatants were collected and the titre of released virus
measured by plaque assay, while the infected cells were
fixed and examined by fluorescent microscopy for cell-
surface HA and internal actin. The lowest dose of drug
tested (0.3 M) was sufficient to cause marked clumping
of the cortical actin web, while higher doses caused
complete collapse of the actin cytoskeleton and round-
ing and aborization of the cells (data not shown, but see
Fig. 2). However, no reduction in virus titre was seen at
any concentration of drug for either virus (Table 1). In
replicate experiments, even the highest concentration of
drug tested (3 M) did not reduce the release of infec-
tious Udorn virus, as titres in the absence of drug were
6.3  3.4  106 PFU/ml compared to 5.7  1.1  106
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PFU/ml in the presence of drug (n  4). The apparent
failure of the drugs to inhibit virus replication was not an
artifact arising from carryover of input virus because
parallel experiments using other drugs such as leptomy-
cin B (Elton et al., 2001) or methyl--cyclodextrin (data
not shown) did show reduced titres of released virus.
Consistent with the lack of effect on virus release, par-
allel analysis of polypeptide synthesis by metabolic la-
belling or Western blot showed no discernible effects of
jasplakinolide treatment on viral protein synthesis (data
not shown). Mock-infected, HA-stained samples showed
low levels of nonspecific antibody binding (Fig. 1f and
data not shown). In the absence of jasplakinolide, Udorn
infection produced distinctive HA-stained filamentous
structures on the cell surface, which reached several
microns in length (Fig. 1a). In contrast, PR8 infection
produced a stippled staining pattern, with HA distributed
irregularly over the cell surface (Fig. 1d). The differing HA
distributions reflect the very different budding strategies
of the two viruses. In the presence of jasplakinolide,
Udorn infection no longer produced filamentous virions
and instead, HA was found clumped into ring-shaped
domains distributed across the surface of the cell (Fig.
1b). Under higher power magnification these domains
were seen in many cases to show a clear annular struc-
ture (Fig. 1c, top). These annuli of HA were distinctive in
shape and distribution and their size was found to be
regular (1.8  0.3 m in diameter, n  99, two indepen-
dent experiments). When data from confocal microscopy
was used to recreate a cross-sectional view from serial
optical planes of focus, the annuli appeared as hemi-
TABLE 1
Effect of Actin-Binding Drugs on Influenza Virus Replication
Drug
% Titre in absence of drug
A/Udorn/72 A/PR/8/34
Jasplakinolide (M)
0.3 160 150
1.0 100 180
3.0 340 130
Latrunculin A (nM)
0.2 109
0.6 100
1.7 155
5 173
MDCK cells were infected with influenza viruses in the presence of
drugs as indicated and released titres at 8 h p.i. measured on MDCK
cells. Values are expressed as the percentage of titres obtained in the
presence of the drug solvent, DMSO. 100% values for A/Udorn/72
ranged between 1.1 and 1.5  106 pfu/ml, while those for A/PR/8/34
were 5  107 pfu/ml.
FIG. 1. Effect of jasplakinolide treatment on the distribution of cell surface HA in influenza virus infected cells. MDCK cells were mock infected (f)
or infected (a–e) with the Udorn (a–c) or PR8 (d–e) strains of influenza virus and in certain cases incubated with 0.3 M jasplakinolide (Jasp) as
indicated. 8 h p.i. cells were fixed, stained for cell surface HA, and imaged by confocal microscopy. Extended focus projections are shown, except
for the lower portion of (c), which shows a z-axis reconstruction.
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spherical protrusions from the surface of the plasma
membrane (Fig. 1c, bottom). The formation of these an-
nuli was not peculiar to the filamentous virus as similar
domains were observed in drug-treated, PR8-infected
cells (Fig. 1e). The rings of PR8 HA observed in cells
treated with jasplakinolide were of a similar size and
distribution to those seen in cells infected with Udorn.
Thus inhibition of actin depolymerization as well as po-
lymerisation blocks the assembly of filamentous influ-
enza virions without decreasing the overall titre of re-
leased virus. Furthermore, jasplakinolide treatment leads
to the specific reorganisation of cell-surface HA into
annular aggregations irrespective of whether the virus
strain normally produces spherical particles only, or a
mixture of filamentous and spherical particles.
Treatment of cells with jasplakinolide leads to specific
changes in the distribution of HA. It was therefore of
interest to determine the nature of the disruption to the
actin cytoskeleton which was responsible for these
changes. Accordingly, we examined whether actin and
cell-surface HA colocalised in Udorn-infected cells with
and without jasplakinolide treatment. To detect actin we
used either a monoclonal antibody specific for the -ac-
tin isoform or a fluorescently tagged phalloidin as a
general probe for F-actin. As expected, -actin in un-
treated cells was distributed as a layer of cortical actin
underlying the plasma membrane (Fig. 2a, ii). Counter-
staining for HA showed viral filaments budding from the
plasma membrane, often in arrays in close proximity to
the underlying -actin (Fig. 2a, i, iii). However, no evi-
dence for significant incorporation of actin into the viral
filaments was observed (Fig. 2a and data not shown). In
drug-treated cells, surface HA was again reorganised
into the characteristic annular structures distributed
across the cell surface (Fig. 2a, iv). Staining for -actin in
drug-treated cells showed complete loss of the cortical
actin web with the actin instead aggregated into discrete
clumps distributed across the cell (Fig. 2a, v). Strikingly,
each focal cluster of -actin was located in the center of
a cell-surface annulus of HA (Fig. 2a, vi). z-Axis recon-
structions showed that the aggregations of actin were
positioned just below the plasma membrane underneath
and partially inside the surrounding rings of viral HA (Fig.
2b). When infected, drug-treated cells were stained with
fluorescent phalloidin, a similar array of punctate spots
of F-actin were seen (Fig. 2c, ii), although interestingly,
under these conditions the network of basement stress
fibres was largely intact (data not shown). Moreover,
high-power magnification showed that each punctate
focus of F-actin was at the center of an annulus of
cell-surface HA and that although the segregation of the
two proteins was clearly linked, there was very little
direct colocalisation of the two fluorophores (Fig. 2c, i,
iii). Thus the redistribution of cell-surface HA after jas-
plakinolide treatment is accompanied by a matching
reorganisation of the underlying actin cytoskeleton.
Jasplakinolide and cytochalasin D disrupt the actin
cytoskeleton by different mechanisms and yet both in-
hibit the assembly of filamentous influenza virions. In the
case of jasplakinolide treatment, the collapse of the
cortical actin web is associated with a corresponding
reorganisation of cell-surface HA into annuli. We there-
fore tested if this phenomenon was unique to jasplakino-
lide or whether other actin-disrupting drugs also caused
HA reorganisation. MDCK cells were infected with Udorn
and treated 1 h p.i. with latrunculin A or cytochalasin D.
Latrunculin A inhibits actin polymerisation by sequester-
ing G-actin monomers and thus disrupts the actin tread-
milling cycle in a mechanistically distinct way from cy-
tochalasin D and jasplakinolide (Coue et al., 1987). At 8 h
p.i., cells were fixed and stained for F-actin and HA. Very
few viral filaments were visible in cells treated with
latrunculin A; instead cell-surface HA was clumped into
aggregations, often ring-shaped (Fig. 3a). The rings of
HA observed in latrunculin A treated cells were of a
similar size to those observed in the presence of jas-
plakinolide (around 1.5 m diameter). Also similarly to
jasplakinolide, latrunculin A induced the formation of
punctate aggregations of F-actin which coincided with
the centre of the HA aggregations (Figs. 3b and 3c). In
addition, when the titres of released virus were mea-
sured, there was no apparent reduction in virus replica-
tion across a range of latrunculin A concentrations (Table
1), implying that spherical particle production was unaf-
fected. Next, we tested the effects of cytochalasin D and
found that as previously reported (Roberts and Compans,
1998), it disrupted filament formation by Udorn (Fig. 3d).
Furthermore, after drug treatment, the viral HA formed
clumps which colocalised with punctate aggregations of
F-actin, although neither the actin foci or the correspond-
ing HA reorganisation was as distinct as with the other
two inhibitors (Figs. 3e and 3f). Thus, three drugs which
disrupt the actin treadmilling cycle in different ways in-
duce the formation of punctate aggregations of F-actin
and prevent the assembly of long filamentous virions,
without any apparent inhibitory effect on overall virus
replication. Furthermore, in each case the collapse of the
cortical actin web is accompanied by a matching rear-
rangement of cell-surface HA into distinctive, often an-
nular aggregations.
Scanning electron microscopy (SEM), atomic force mi-
croscopy (AFM), and transmission electron microscopy
(TEM) were used to study the morphology of the annular
domains formed after actin disruption. MDCK cells were
infected with Udorn and then incubated in the presence
or absence of jasplakinolide. At 8 h p.i., cells were fixed
and prepared for microscopy. In the absence of drug,
SEM showed virus filaments measuring several microns
in length on the surface of infected cells (Fig. 4a). Mi-
crovilli were also observed, distributed evenly across the
cell surface. In the presence of jasplakinolide, long viral
filaments were greatly reduced in number but clumps of
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short filaments were observed, distributed across the
cell surface (Fig. 4b). Closer examination of these struc-
tures showed short filaments apparently radiating from a
focal point, with an overall diameter of 1–2 M (Fig. 4b,
inset). The occasional longer filamentous structure ob-
served in drug-treated cells originated from these
clumps of short filaments. AFM imaging also showed
virus filaments several microns in length budding from
the surfaces and edges of infected cells incubated in the
absence of drug (Fig. 4c). In addition, the filaments were
often organised in parallel bundles (Fig. 4c, ii). In the
presence of jasplakinolide, clumps of filaments strikingly
similar to those observed using SEM were seen (Fig. 4d).
Again, these domains were roughly circular and resem-
bled short filaments radiating from a central point. TEM
imaging of infected cells in the absence of drug treat-
ment showed the presence of a mixture of short and long
filamentous structures close to or actually budding from
the plasma membrane (Fig. 4g, arrows) as well as ap-
parently spherical virus particles (Fig. 4e, arrows). How-
ever, after jasplakinolide treatment, no long filaments
were visible and the cell surfaces were instead deco-
rated with a mixture of short filaments and numerous
spherical virus particles (Figs. 4f and 4h). In addition, the
short filaments that were apparently attached to the
plasma membrane often appeared to be clumped (Fig.
4f, arrows), consistent with the three-dimensional SEM
and AFM images. Thus jasplakinolide-induced actin dis-
ruption leads to physical alteration of the surface struc-
ture of the plasma membrane without preventing the
assembly and release of spherical influenza virions. We
conclude that the drug-induced aggregations of short
filamentous structures most likely correspond to the
rings of HA seen by confocal immunofluorescence mi-
croscopy.
The intracellular viral components M1 and NP
redistribute with HA in response to actin disruption
Destruction of the cortical actin web inhibited the for-
mation of long viral filaments and led to reorganisation of
cell-surface HA (Figs. 1–4) but did not decrease the
overall titre of released spherical virions (Table 1). There-
fore it seemed possible that the rings of cell-surface HA
corresponded to reorganised viral budding sites. To test
this hypothesis, we examined whether the subcellular
distribution of the major internal components of the virion
altered in response to jasplakinolide treatment. MDCK
cells were infected with Udorn virus, incubated in the
presence or absence of jasplakinolide, permeabilised
8 h p.i. using 1% TX-100 at 4°C, and then fixed and
examined by confocal microscopy after staining for NP.
In the absence of the drug, RNP staining showed fila-
mentous viral structures, while mock-infected cells
showed very little staining (Figs. 5c and 5d). In jas-
plakinolide-treated cells filaments were not seen; in-
stead aggregations of RNP were observed (Fig. 5a),
which under higher power magnification showed distinct
circular patterns (Fig. 5b). These rings of RNP were of a
similar diameter to those observed previously for HA
(around 1.5 m).
Next, we examined the distribution of M1. To permit
noninvasive tracking of M1 and to allow colocalisation
studies with HA, we utilised an M1-green fluorescent
protein (GFP-M1) fusion. MDCK cells were transfected
with plasmid pGFPM703 encoding a GFP-M1 fusion pro-
tein under the control of a cytomegalovirus immediate
early promoter (or with plasmid pEGFP-c2 expressing
GFP alone) and 18 h later, some cultures were superin-
fected with Udorn and treated with jasplakinolide. At 8 h
p.i., the cells were fixed, stained for cell-surface HA, and
examined by confocal microscopy. In the absence of
drug in infected cells, both GFP-M1 and GFP (data not
shown) showed a mixture of nuclear and cytoplasmic
accumulation, consistent with the presence of a nuclear
localisation signal in M1 (Ye et al., 1995) and the ability of
nonfused GFP to transfer passively into the nucleus
because of its relatively small size. However, while GFP
alone displayed diffuse cytoplasmic localisation, a sub-
stantial proportion of the cytoplasmic GFP-M1 was in the
form of filamentous structures (Fig. 6a, ii). When the
surface distribution of HA was examined, pGFPM703-
transfected cells displayed numerous viral filaments (Fig.
6a, i) and these HA-containing structures colocalized
with those of the GFP-tagged M1 in merged images (Fig.
6a, iii), indicating incorporation of GFP-M1 into viral fila-
ments. z-Axis reconstructions of bundles of viral fila-
ments projecting away from the surface of infected cells
showed marked colocalisation of HA and GFP-M1 (Fig.
6b, i), but no detectable incorporation of GFP alone (Fig.
6b, ii), confirming that GFP-M1 was specifically incorpo-
FIG. 2. Jasplakinolide induced collapse of the cortical actin web leads to matching changes in cell-surface HA distribution. MDCK cells were
infected with Udorn virus and treated with 0.3 M jasplakinolide (J) or left untreated (J) as before, fixed at 8 h p.i., and examined by fluorescent
staining and confocal microscopy for the distribution and codistribution (merged images) of HA and -actin as indicated using the appropriate
antibodies (a, b), or F-actin using Alexa-594-conjugated phalloidin (c). Images are extended focus projections except for those in (b) which are z-axis
reconstructions.
FIG. 3.Mechanistically different inhibitors of actin treadmilling cause the formation of punctate spots of F-actin surrounded by clumps of cell surface
HA. MDCK cells were infected with Udorn virus and treated from 1 h p.i. with 3 nM latrunculin A (a–c) or 0.5 g/ml cytochalasin D (d–f). At 8 h p.i.
cells were fixed and stained for HA and F-actin using fluorescently labelled phalloidin (as labelled) and examined by confocal microscopy. Extended
focus projections are shown.
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FIG. 4. Physical features of the surface of Udorn infected cells. MDCK cells were infected with Udorn virus and incubated in the presence (b, d,
f, h) or absence (a, c, e, g) of 0.3 M jasplakinolide. At 8 h p.i. cells were fixed and imaged by SEM (a, b), AFM (c, d), or TEM (e–h). Arrows indicate
(e) clusters of apparently spherical virus particles; (f) possible clusters of short filaments; (g) virus particles in close proximity to the plasma membrane,
possibly in the process of pinching-off.
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rated into viral filaments. In addition, no large filamen-
tous structures were seen in uninfected cells transfected
with pGFPM703 (Fig. 6b, iii). Thus GFP-tagged M1 is
competent to interact with wild-type viral components
and to be incorporated into budding virions. We therefore
went on to examine the effect of jasplakinolide treatment
on GFP-M1 localisation in virus-infected cells. In drug-
treated cells, surface HA displayed the characteristic
annular staining pattern (Fig. 6a, iv). Under these condi-
tions, GFP-M1 was not found in filamentous structures,
but was also located in focal aggregates, many of which
showed a ring-like appearance and all of which colo-
calised with the HA annuli (Fig. 6a, v, vi). Under high-
power magnification, the two fluorophores were found in
close proximity at the nanometer level (Fig. 6a, vii–ix).
Thus disruption of the actin cytoskeleton leads to reor-
ganisation of the two major cytosolic components of
influenza virions. This supports the hypothesis that the
drug-induced annuli of cell-surface HA correspond to
reorganised viral budding sites. This is also consistent
with the study of Avalos et al. (1997), which showed
colocalisation of M1 and NP with actin in membrane
blebs at the periphery of markedly arborized cells after
cytochalasin D treatment.
Filamentous influenza virions are associated with lipid
raft structures
Strains of influenza virus which produce solely spher-
ical virions have been shown to exploit lipid raft domains
for the purpose of assembly and budding (Scheiffele et
al., 1999; Zhang et al., 2000). We therefore tested whether
this was the case for the vastly larger virus particles
produced by the filamentous Udorn strain and also for
FIG. 5. RNP and HA distribution in detergent-extracted cells. MDCK cells were infected (or mock infected; d) with Udorn virus and were either
incubated with 0.3 M jasplakinolide from 1 h p.i. (a, b, f) or left untreated (c–e). At 8 h p.i. cells were extracted on ice with 1% TX-100, fixed, and
immunostained for NP (a–d) or HA (e, f). Confocal extended focus projections are shown.
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the annular HA structures induced by cytoskeletal dis-
ruption. The primary experimental definition of lipid rafts
and their associated polypeptides is their insolubility in
nonionic detergent at low temperatures (Brown and
Rose, 1992; Fiedler et al., 1993). Accordingly, 8 h p.i.,
Udorn-infected MDCK cells were incubated at 4°C in
buffer containing 1% Triton X-100 (TX-100) for 30 min.
Cells were then washed, fixed, and examined by confo-
cal microscopy after staining for HA. In the absence of
jasplakinolide treatment, filaments incorporating HA
were visible that were of a similar length to those seen in
experiments where the cells were fixed without prior
detergent extraction (Fig. 5e). As before, no viral fila-
ments were observed in drug-treated cells, and instead,
HA staining was reorganised into annular domains (Fig.
5f). These had survived detergent extraction and ap-
peared of similar size, intensity, and abundance to those
observed in the absence of detergent extraction. Thus,
HA in both filamentous virions and drug-induced annuli
is resistant to in situ extraction with nonionic detergent at
4°C, consistent with its presence in lipid raft domains.
The in situ low-temperature detergent insolubility of
Udorn HA described above could potentially result not
from its incorporation into lipid rafts, but from an asso-
ciation with other insoluble nonmembranous viral and/or
cellular structures. To test this possibility, we examined
whether the filamentous Udorn HA partitioned into low
buoyant density detergent-insoluble glycolipid domains,
as has previously been demonstrated for the HAs from
the spherical virions produced by the other influenza
strains studied (Scheiffele et al., 1999; Zhang et al., 2000).
For the purposes of comparison, we also examined the
FIG. 6. A GFP-M1 fusion protein is incorporated into budding viral filaments and redistributes in response to actin disruption. MDCK cells were
transfected with plasmid pGFPM703 (a, b i, iii) or pEGFP-c2 (b ii), superinfected with A/Udorn/72 (a, b i, ii) or mock-infected (b iii), and incubated in
the presence (a iv–ix) or absence (a i–iii; b) of 0.3 M jasplakinolide from 1 h p.i. At 8 h p.i. cells were fixed, stained for surface HA in red and examined
by confocal microscopy for HA and GFP distribution. (a) shows extended focus projections. (b) shows z-axis reconstructions of HA and GFP
distribution from the indicated combinations of plasmid and virus.
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behaviour of the nonfilamentous PR8 strain HA. MDCK
cells were infected with either virus, and at 8 h p.i.,
extracted in buffer containing 1% TX-100 at 4°C for 30
min. The cell lysates were then adjusted to 40% sucrose
(w/v) and loaded at the bottom of a discontinuous su-
crose gradient. Following centrifugation, fractions were
collected and analysed for HA content by Western blot-
ting. Substantial quantities of the PR8 HA partitioned into
the upper part of the sucrose gradient, indicating its
association with a detergent insoluble membrane frac-
tion (Fig. 7a). The proportion of HA seen in the upper and
lower halves of the gradient was estimated by densitom-
etry. In replicate experiments, 49  8% (n  4) of the HA
was found in low buoyant density fractions. When cells
infected with A/Udorn/72 were studied, the H3 HA be-
haved similarly to the PR8 HA and partitioned approxi-
mately equally between buoyant (45  12%, n  4) and
nonbuoyant fractions (Fig. 7c). This is consistent with
previous results testing the raft association of an
A/Udorn/72 HA in a WSN genetic background that does
not produce significant numbers of filamentous particles
(Zhang et al., 2000). Therefore the HA from a filamentous
strain of influenza virus displays a similar degree of
association with detergent-insoluble lipid raft structures
to the HA from a nonfilamentous strain. Next, we exam-
ined whether cytoskeletal disruption (and the accompa-
nying reorganisation of the surface HA) had any effect on
the HA-DIG association. When extracts from infected
cells incubated in the presence of jasplakinolide were
fractionated, neither strain of HA showed any significant
change in its degree of DIG association (Figs. 7b and 7d),
with 48  16% (n  4) and 43  6% (n  3) of the PR8
and Udorn HAs, respectively, still partitioning into low
buoyant density fractions. Thus the HA in filamentous
influenza virions is associated with lipid rafts.
DISCUSSION
Assembly of filamentous influenza virus particles has
been proposed to depend on the actin cytoskeleton,
based on their sensitivity to the inhibitor of actin poly-
merisation, cytochalasin D (Roberts and Compans,
1998). Here, this hypothesis was strengthened by testing
the effect of drugs which perturb the actin treadmilling
cycle through different mechanisms. Jasplakinolide, an
inhibitor of actin depolymerisation, and latrunculin A, a
G-actin binding drug, were both found to prevent the
assembly of filamentous but not spherical virus particles
(Figs. 1, 3, 4, and Table 1). Thus the loss of filament
production in cytochalasin D treated cells (Roberts and
Compans, 1998) is not unique to this drug and does
reflect a requirement for the microfilament network. This
is noteworthy since the closely related drug cytochalasin
B has been shown to inhibit release of influenza virions
from infected cells, not by interfering with the assembly
process but because cytochalasin B has a unique effect
on the glycosylation of the neuraminidase (Griffin and
Compans, 1979).
We also show that disruption of the microfilament
network leads to the formation of a previously unrecog-
nised annular structure on the surface of infected cells.
Physically, this structure consisted of a regularly sized
clump of short filaments radiating away from a focal
point (Fig. 4). These annuli incorporated HA on the cell
exterior, and on the cytoplasmic surface of the plasma-
membrane, M1 and RNP, arranged around aggregations
of polymerised -actin (Figs. 2, 5, 6, and 8). Formation of
these annuli was most marked following jasplakinolide
treatment but could also be observed after treatment
with cytochalasin D and latrunculin A (Fig. 3). Cortical
aggregations of actin have previously been observed
following cytochalasin D and jasplakinolide treatment or
microinjection of phalloidin, which acts similarly to jas-
plakinolide (Wehland et al., 1977; Schliwa, 1982; Bubb et
al., 1994, 2000). To our knowledge, however, this is the
first time it has been shown that the formation of such
structures is accompanied by a matching distinctive re-
organisation of membrane-associated proteins. Longer
viral filaments were sometimes seen protruding from
annuli, an effect that was particularly marked when drug
treatment was initiated at 4 h p.i., just prior to the onset
of detectable filament production (data not shown). In
addition, the effect of jasplakinolide treatment was re-
versible, since removal of the drug was accompanied by
recovery of the cortical actin web, loss of HA annuli, and
the resumption of filament production (data not shown).
FIG. 7. Sucrose floatation gradient analysis of low temperature deter-
gent extracted cell lysates. MDCK cells were infected with A/PR/8/34 or
A/Udorn/72 as indicated and incubated from 1–8 h p.i. in the presence (b,
d) or absence (a, c) of 0.3 M jasplakinolide. Following extraction with
TX-100 at 4°C, cells were loaded at the bottom of a sucrose floatation
gradient and subjected to centrifugation. Fractions (numbered from the
bottom of the gradient) were collected and examined for HA content by
Western blot. P  pellet. Percentages show the amounts in the top and
bottom halves of the gradient as determined by densitometry.
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Thus the formation of annular domains is concomitant
with the loss of normal filament assembly. We therefore
postulate that as the cortical actin network collapses into
punctate aggregations, viral filaments and viral assembly
sites are dragged in to surround them. After actin dis-
ruption, the spherical virion production that still occurs is
likely to take place at the annuli, since HA, M1, and NP
accumulate in these domains. This is consistent with the
finding that the HA of the PR8 strain of influenza (which
only produces spherical particles) also redistributes into
annular domains after jasplakinolide treatment (Fig. 1e).
Thus the finding that the main viral structural proteins
relocalise specifically in response to cytoskeletal disrup-
tion indicates that influenza virion assembly occurs at
specific regions of the plasma membrane that are linked
to the actin cytoskeleton. In addition, the matching redis-
tribution of HA, M1, and NP after cytoskeletal disruption
is consistent with the existence of interactions between
these components that are involved in virion assembly.
However, it does not rule out the possibility of additional
or alternative independent interactions with a common
cellular component, of which the actin aggregation at the
center of the annuli is the most obvious candidate. Such
a hypothesis is supported by the ability of NP to bind
F-actin (Digard et al., 1999, 2001) and it would be inter-
esting to examine the behaviour of recombinant influ-
enza viruses encoding NP mutants with defects in actin
binding, if such viruses can be generated.
It is not self-evident why actin disruption and the
formation of annuli should preclude the formation of
filamentous but not spherical virions. Similar to others,
we have found no convincing evidence for the incorpo-
ration of actin into viral filaments budding from cells. Not
only do we see no significant staining of filaments with
anti- actin (Fig. 2a), we have been unable to consis-
tently detect actin in filaments by staining with fluores-
cently labelled phalloidin, cytochalasin D, actin, or the
actin-binding protein cofilin (data not shown). Equally,
cytoskeletal disruption is not accompanied by any ap-
parent gross defect in the transport of influenza virion
components to the sites of virus assembly. Although we
have not directly examined whether annuli also incorpo-
rate NA, M2, NEP/NS2, and the polymerase complex
(because of the lack of suitable antibodies for the first
two and the low abundance of the latter pair), the major
internal virion components assemble at annuli (Figs. 5
and 6) and spherical virion assembly continues unaf-
fected (Table 1, Fig. 4). Strains of influenza which produce
predominantly spherical virions have previously been
shown to bud from lipid raft domains in the plasma
membrane, and several studies have investigated the
requirements for HA and NA association with these do-
mains (Scheiffele et al., 1997, 1999; Keller and Simons,
1998; Barman and Nayak, 2000; Zhang et al., 2000). Here,
the study of influenza virus and its interactions with lipid
raft domains was extended to the filamentous influenza
virus A/Udorn/72. The HA protein of this virus was also
found to be raft-incorporated, being insoluble in the non-
ionic detergent TX-100 at 4°C and present in DIGs fol-
lowing sucrose density gradient centrifugation (Figs. 5
and 7). In addition, filamentous virus particle production
was inhibited by cholesterol depletion with the drug
methyl--cyclodextrin at concentrations which did not
prevent transport of HA to the cell surface (M. Simpson-
Holley and P. Digard, unpublished data). We conclude
that filamentous virus particles, similar to spherical vi-
ruses, bud from lipid raft domains in the plasma mem-
brane. The annular domains seen after treatment with
actin-disrupting drugs also showed characteristics typi-
cal of lipid rafts. Hence annuli also appear to be con-
structed from lipid rafts and this in turn supports the
hypothesis that they correspond to aggregated viral bud-
ding domains.
The observation that the major structural polypeptides
of influenza virus specifically redistribute in response to
disruption of the cortical actin web provides further sup-
port for the prevalent hypothesis that lipid rafts interact
with the actin cytoskeleton in a manner that controls their
distribution. Previously, lipid rafts have been observed in
single particle tracking experiments to behave as if teth-
ered to an underlying structure, for which the membrane-
associated cytoskeleton is an obvious candidate (Pralle
et al., 2000), while biochemical analysis of low-density
DIG fractions often shows the presence of actin (Chang
et al., 1994; Dermine et al., 2001). Several studies have
shown that manipulation of raft-associated glycoproteins
can lead to matching rearrangement of underlying mi-
crofilaments, particularly in the context of T cell signal-
ling (Deckert et al., 1996; Janes et al., 1999; Harder and
Simons, 1999; Oliferenko et al., 1999; Roper et al., 2000;
Stahlhut and van Deurs, 2000; reviewed by Simons and
Toomre, 2000). However, we are unaware of previous
studies which show the converse, that manipulation of
the actin cytoskeleton by a variety of drugs leads to the
formation of a specific lipid-raft-containing structure on
the cell surface.
The finding that lipid raft organisation is disrupted by
cortical actin rearrangements in the presence of actin-
disrupting drugs raises the possibility that this disruption
is responsible for the loss of filamentous virus budding.
The question remains though, of why the loss of normal
raft organisation should specifically affect filamentous
but not spherical virus assembly. Filamentous influenza
virions are very large structures; quantification of the size
of the filaments produced by the virus–cell combination
used in this study indicated an average length of 11  4
m (n  102). This is orders of magnitude larger than
the estimated size of single lipid raft domains (Kenworthy
and Edidin, 1998; Varma and Mayor, 1998; Pralle et al.,
2000; Schutz et al., 2000) and far larger than any known
examples of specialised raft assemblages yet described,
such as caveolae (Harder and Simons, 1999; Kurzchalia
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and Parton, 1999). Theoretically, at its simplest, the entire
lipid envelope of a spherical virus particle of 100 nm
diameter could be supplied by a single lipid raft of
around 200 nm diameter, less than the mean size of the
lipid domains measured by Schutz et al. (2000). However,
a 10-m-long viral filament has approximately 100 times
the surface area of a similar diameter sphere, so the
construction of a viral filament even partially composed
of raft lipid would require a much larger number of raft
domains. We therefore propose that the assembly of
filamentous virions requires the actin cytoskeleton be-
cause filaments grow by incorporating multiple separate
lipid raft domains and the mobility of HA-containing lipid
rafts is subject to control by microfilaments. In this
model, filamentous virion assembly fails after cytoskel-
etal disruption because the consequent aggregation of
raft domains into annuli surrounding actin cores inter-
feres with the serial recruitment of lipid rafts necessary
to maintain filament growth. In contrast, the assembly of
spherical virus particles remains unaffected because of
the much smaller number of raft domains necessary for
the formation of a single virus particle.
Interestingly, a recent study examining the bud-
ding morphology of human parainfluenza virus type 2
(HPIV-2) found that filament formation was inhibited by
jasplakinolide or cytochalasin D treatment without sig-
nificant effect on the overall titre of released virus at 24 h
p.i. (Yao and Compans, 2000). The authors suggested
that filamentous virion assembly requires the cytoskele-
ton to maintain cell polarity, a factor shown to be impor-
tant for both influenza virus and HPIV-2 filament assem-
bly (Roberts and Compans, 1998; Yao and Compans,
2000). However, jasplakinolide treatment induced the
formation of small clumps of HPIV-2 surface antigens
and although confocal microscopy was not used or actin
distribution examined, it is possible these structures are
equivalent to the HA annuli described here. To our
knowledge, it is not known whether HPIV-2 utilises lipid
rafts for budding: the hypothesis that the cytoskeleton
controls and maintains the necessary raft dynamics for
filamentous virion assembly predicts that it does.
MATERIALS AND METHODS
Cells, antibodies, and reagents
MDCK cells with a transepithelial electrical resistance
of 800 /cm2 were used. Cells were grown on glass
coverslips for immunofluorescence, AFM, and SEM, and
on tissue culture plates for TEM and biochemical exper-
iments. Cells were cultured in Dulbecco’s modified Ea-
gle’s medium supplemented with L-glutamine, penicillin,
streptomycin, and 10% foetal calf serum.
Rabbit antiserum to influenza virus recombinant A/X/31
(H3N2) was a kind gift of Dr. D. Steinhauer, NIMR, Mill
Hill. This antiserum was used to stain for the extracellu-
lar viral proteins of Udorn virus and has been shown to
detect mainly the haemagglutinin (data not shown). Rab-
bit polyclonal antibody to RNP has been previously de-
scribed (Digard et al., 1999). TRITC-conjugated phalloidin
and anti--actin (clone AC-74) were purchased from
Sigma. Jasplakinolide, latrunculin A, and anti-rabbit IgG
antibodies conjugated to Alexa 594 were purchased from
Molecular Probes Ltd. Cytochalasin D was purchased
from Sigma-Aldrich Ltd. Drugs were dissolved in dimethyl-
sulphoxide (DMSO) and DMSO included alone as a control
in all experiments. Anti-rabbit and anti-mouse antibodies
conjugated to FITC were purchased from DAKO.
Plasmid pGFPM703, encoding a GFP-M1 gene fusion
under the control of a cytomegalovirus immediate early
promoter, was constructed by cloning a cDNA copy of
segment 7 from A/PR/8/34 (Young et al., 1983) into plas-
mid pEGFP-C2 (Clontech). A product of the expected size
(54 kDa) was detected by Western blot using anti-M1 and
anti-GFP antibodies (data not shown).
Virus infections and transfections
Influenza virus A/Udorn/72 was a kind gift of Dr. R.
Compans, Emory University, Atlanta (Roberts and Com-
pans, 1998). The virus was grown in MDCK cells in the
presence of 1 g/ml trypsin and 0.14% bovine serum
albumin. The supernatant was clarified, titred by serial
dilution on MDCK cells, and was stored at 70°C until
use. The Cambridge line of A/PR/8/34 was propagated in
embryonated eggs as previously described (Blok et al.,
1996; Elton et al., 2001), titred, and stored as described
above. Cell monolayers were washed with PBS and
infected at a multiplicity of infection of 10 for 1 h at 37°C.
Cells were then washed and incubated in medium in the
presence or absence of drug as desired. At 8 h p.i. cells
were fixed for microscopy or prepared for extraction of
raft membranes as described below. Cells were trans-
fected with plasmids (0.3 g/105 cells) using Lipofectin
(GIBCO-BRL) according to the manufacturer’s instruc-
tions (Digard et al., 1999).
Microscopy
For immunofluorescence, cells were washed in PBS,
fixed with 4% formaldehyde in PBS at room temperature
for 20 min, and washed with PBS containing 2% newborn
calf serum (NCS). Cells were incubated with primary
antibodies and bound antibody detected by use of ap-
propriate fluorophore-conjugated secondary antibody
(Digard et al., 1999; Elton et al., 2001). Coverslips were
mounted in Prolong antifade reagent (Molecular Probes)
and examined using a Leica TCS NT confocal micro-
scope. To generate images of whole cells, serial optical
planes of focus (at 0.5-m intervals) were taken in the
z-axis through the depth of the cell and merged into one
image using the extended focus algorithm in the soft-
ware package TCS-NT (Leica). z-Axis (“side-view”) recon-
structions were generated from similar serial optical
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planes of focus taken through the depth of the cell using
the orthogonal view algorithm in TCS-NT. Laser power
and photomultiplier tube settings were kept identical
between matching samples stained with the same anti-
body. For SEM, cells were washed in 0.1 M HEPES pH
7.4, 2 mM CaCl2 and fixed overnight in the same buffer
containing 0.3% H2O2 and 4% EM-grade glutaraldehyde
(Sigma; HEPES–glutaraldehyde). Cells were washed,
fixed again in 1% osmium tetroxide, and dehydrated in
serial alcohol dilutions. Samples were dried in a Polaron
E 3000 critical point drier, sputter coated with AuPd to a
thickness of 5 nm using a Polaron E5000, and viewed
under a Philips XL 30 FEG SEM. For AFM, cells were
fixed with glutaraldehyde as described for SEM, washed
with distilled water, and air dried. Samples were ob-
served using a Digital Instruments MultiMode AFM un-
der the control of a Nanoscope IIIa controller. Digital
Instruments Nanoprobe AFM tips (spring constant of
0.38 N/m) were used for contact-mode imaging. For TEM,
monolayers of cells grown in 5-cm tissue culture dishes
were washed in 0.1 M HEPES pH 7.4. The monolayer was
then covered in HEPES–glutaraldehyde and left at 4°C
for 1.5 h. The monolayer was then washed with HEPES
buffer and cells scraped into buffer and harvested by
centrifugation at 13,000 rpm for 10 min. The supernatant
was then replaced with fresh HEPES buffer and sent to
Cambridge University Multi-Imaging Centre, Department
of Anatomy, for further fixation and sectioning.
Isolation of glycosphingolipid-rich TX100-insoluble
membrane fractions
Confluent cell monolayers were washed twice (on ice
at 4°C) with ice-cold PBS and overlaid with 1% TX100 in
25 mM Tris pH 7.5, 150 mM NaCl, 15 mM EDTA (TNE)
(Manie et al., 2000) on ice for 30 min. The cells were then
scraped off and the suspension adjusted to 40% sucrose
in TNE. Samples were transferred to centrifuge tubes
and overlaid with steps of 30 and 4% sucrose in TNE.
Gradients were spun at 36,000 rpm in a Beckmann SW55
rotor for 16 h at 4°C. Fractions were collected from the
bottom of centrifuge tubes and analysed by Western
blotting. Secondary antibodies conjugated to horserad-
ish peroxidase were used (DAKO) and bound antibody
detected by chemiluminescence (ECL reagent, Amer-
sham). Luminescence was quantified using an Alpha
Innotech Corporation Multi-Image cabinet according to
the manufacturer’s instructions.
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